World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
76
Citations
28942
World Ranking
1388
National Ranking
607

Medicine

D-Index
82
Citations
31689
World Ranking
15926
National Ranking
8017

Overview

Susan F. Leitman is affiliated with the National Institutes of Health in the United States. Their research primarily spans the fields of Medicine and Business, Management and Accounting, with a focused interest in the subfields of Management of Technology and Innovation, Biochemistry, Hematology, Public Health, Environmental and Occupational Health, and Oncology.

Leitman's work extensively covers topics related to blood donation and transfusion practices, blood transfusion and management, erythropoietin and anemia treatment, organ donation and transplantation, hematopoietic stem cell transplantation, neutropenia and cancer infections, and transplantation methods and outcomes.

Among their recent publications are:

  • Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology-enabled nomogram, 2021, published in Transfusion
  • Source plasma collection in the United States: Toward a more personalized approach, 2020, published in American Journal of Hematology
  • Repeat donation and deferral rates in US source plasma donors: Exploratory analysis from the IMPACT trial, 2021, published in Transfusion
  • Granulocyte transfusions in severe aplastic anemia, 2023, published in Haematologica

Leitman frequently collaborates with other researchers. Regular co-authors include Jan Hartmann, Michael J. Ragusa, Mark A. Popovsky, Elmar R. Burchardt, and Zorayr Manukyan.

Their publications appear in several respected scientific journals, notably Transfusion, American Journal of Hematology, and Haematologica.

Best Publications

  • A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

    Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Alfred E. Chang

  • Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

    Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Susan Leitman

  • Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

    Mark E. Dudley;James C. Yang;Richard Sherry;Marybeth S. Hughes

  • Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

    Childs R;Chernoff A;Contentin N;Bahceci E

  • High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.

    Toshihiko Tanno;Natarajan V Bhanu;Patricia A Oneal;Sung-Ho Goh

  • Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller

  • Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer

    Steven A. Rosenberg;Michael T. Lotze;James C. Yang;Suzanne L. Topalian

  • Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.

    Susan J Perlmutter;Susan F Leitman;Marjorie A Garvey;Susan Hamburger

  • Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.

    R. Childs;E. Clave;N. Contentin;D. Jayasekera

  • CCR5 promoter polymorphism and HIV-1 disease progression

    David H McDermott;Peter A Zimmerman;Peter A Zimmerman;Florence Guignard;Cynthia A Kleeberger

  • Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation.

    CE Dunbar;M Cottler-Fox;JA O'Shaughnessy;S Doren

  • Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

    Mark E. Dudley;John Wunderlich;Michael I. Nishimura;David Yu

  • A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.

    Mark E. Dudley;John R. Wunderlich;James C. Yang;Patrick Hwu

  • Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease

    Harry L. Malech;Phillip B. Maples;Narda Whiting-Theobald;Gilda F. Linton

  • Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.

    Joel S. Bennett;James A. Hoxie;Susan F. Leitman;Gaston Vilaire

  • Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis.

    Frederick W. Miller;Susan F. Leitman;Mary E. Cronin;Jeanne E. Hicks

  • Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease

    Tiffany M. Powell;Jonathan D. Paul;Jonathan M. Hill;Michael Thompson

  • Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

    Michael A. Pulsipher;Pintip Chitphakdithai;John P. Miller;Brent R. Logan

  • Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

    Robert E. Walker;Christine M. Bechtel;Ven Natarajan;Michael Baseler

  • Variant Genotypes of the Low-Affinity Fcγ Receptors in Two Control Populations and a Review of Low-Affinity Fcγ Receptor Polymorphisms in Control and Disease Populations

    Thomas Lehrnbecher;Charles B. Foster;Shaoxian Zhu;Susan F. Leitman

Frequent Co-Authors

David F. Stroncek
David F. Stroncek National Institutes of Health
Richard Childs
Richard Childs National Institutes of Health
A. John Barrett
A. John Barrett National Institutes of Health
Cynthia E. Dunbar
Cynthia E. Dunbar National Institutes of Health
Brent R. Logan
Brent R. Logan Medical College of Wisconsin
Harry L. Malech
Harry L. Malech National Institutes of Health
Michael A. Pulsipher
Michael A. Pulsipher University of Utah
Neal S. Young
Neal S. Young National Institutes of Health
Ronald E. Gress
Ronald E. Gress National Institutes of Health
Douglas R. Rosing
Douglas R. Rosing National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various online degrees and career pathways that cater to different professional goals. For those concerned about background challenges, exploring the best degrees for felons can offer insight into education options that support career advancement despite past records.

Healthcare is a growing field with diverse opportunities. For instance, becoming a functional medicine NP combines medical knowledge with holistic care, appealing to microbiology graduates interested in patient-centered roles.

On the administrative side, roles such as a Certified Professional Coder (CPC) are in high demand. Learning about the CPC salary and career paths can help microbiology graduates consider alternative routes that still leverage their scientific background in healthcare settings.

Additionally, the growing importance of data in healthcare highlights careers like healthcare information management salary roles, which blend microbiology knowledge with information technology and management skills, offering robust career options for graduates.

Best Scientists Citing Susan F. Leitman

Trending Scientists

Recently Published Articles